Semi-Synthesis and In Vitro Anti-Cancer Evaluation of Magnolol Derivatives
Xiao-Long Sun,
Mei-Lin Zhu,
Yi-Qun Dai,
Hong-Mei Li,
Bo-Han Li,
Hui Ma,
Chang-Hao Zhang,
Cheng-Zhu Wu
Affiliations
Xiao-Long Sun
School of Pharmacy, Bengbu Medical College, 2600 Donghai Road, Bengbu 233030, China
Mei-Lin Zhu
School of Pharmacy, Bengbu Medical College, 2600 Donghai Road, Bengbu 233030, China
Yi-Qun Dai
School of Pharmacy, Bengbu Medical College, 2600 Donghai Road, Bengbu 233030, China
Hong-Mei Li
School of Pharmacy, Bengbu Medical College, 2600 Donghai Road, Bengbu 233030, China
Bo-Han Li
School of Pharmacy, Bengbu Medical College, 2600 Donghai Road, Bengbu 233030, China
Hui Ma
School of Pharmacy, Bengbu Medical College, 2600 Donghai Road, Bengbu 233030, China
Chang-Hao Zhang
Key Laboratory of Natural Medicines of the Changbai Mountain, College of Pharmacy, Yanbian University, Ministry of Education, 977 Gongyuan Road, Yanji 133002, China
Cheng-Zhu Wu
School of Pharmacy, Bengbu Medical College, 2600 Donghai Road, Bengbu 233030, China
Magnolol (MAG), a biphenolic neolignan, has various biological activities including antitumor effects. In this study, 15 MAG derivatives were semi-synthesized and evaluated for their in vitro anticancer activities. From these derivatives, compound 6a exhibited the best cytotoxic activity against four human cancer cell lines, with IC50 values ranging from 20.43 to 28.27 μM. Wound-healing and transwell assays showed that compound 6a significantly inhibited the migration and invasion of MDA-MB-231 cells. In addition, Western blotting experiments, performed using various concentrations of 6a, demonstrated that it downregulates the expression of HIF-1α, MMP-2, and MMP-9 in a concentration-dependent manner. Overall, these results suggest that substituting a benzyl group having F atoms substituted at the C2 position on MAG is a viable strategy for the structural optimization of MAG derivatives as anticancer agents.